Lawmakers Consider Delaying Drug Rebate Rule To Gain An Offset

By Rachel Cohrs John Wilkerson / April 29, 2019 at 3:08 PM
Congressional Democrats and Republicans are considering delaying the Trump administration’s proposed ban of point-of-sale rebates and using savings from the delay to pay for other legislative priorities, sources said. A drug industry consultant said the savings are likely being eyed as an offset for capping seniors’ annual spending in Medicare Part D. HHS proposed to ban drug rebates in Medicare and Medicaid managed care, starting next year, and the administration is widely expected to follow through on that plan. The...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.